These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

497 related items for PubMed ID: 29141543

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Synergistic Cytotoxicity of Renieramycin M and Doxorubicin in MCF-7 Breast Cancer Cells.
    Tun JO, Salvador-Reyes LA, Velarde MC, Saito N, Suwanborirux K, Concepcion GP.
    Mar Drugs; 2019 Sep 16; 17(9):. PubMed ID: 31527453
    [Abstract] [Full Text] [Related]

  • 23. Taxol induced apoptosis regulates amino acid transport in breast cancer cells.
    Wu Y, Shen D, Chen Z, Clayton S, Vadgama JV.
    Apoptosis; 2007 Mar 16; 12(3):593-612. PubMed ID: 17195090
    [Abstract] [Full Text] [Related]

  • 24. Gef gene therapy enhances the therapeutic efficacy of doxorubicin to combat growth of MCF-7 breast cancer cells.
    Prados J, Melguizo C, Rama AR, Ortiz R, Segura A, Boulaiz H, Vélez C, Caba O, Ramos JL, Aránega A.
    Cancer Chemother Pharmacol; 2010 May 16; 66(1):69-78. PubMed ID: 19771430
    [Abstract] [Full Text] [Related]

  • 25. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
    Menendez JA, Vellon L, Colomer R, Lupu R.
    Int J Cancer; 2005 May 20; 115(1):19-35. PubMed ID: 15657900
    [Abstract] [Full Text] [Related]

  • 26. Epigenetic immunomodulatory effect of eugenol and astaxanthin on doxorubicin cytotoxicity in hormonal positive breast Cancer cells.
    Fouad MA, Sayed-Ahmed MM, Huwait EA, Hafez HF, Osman AM.
    BMC Pharmacol Toxicol; 2021 Jan 28; 22(1):8. PubMed ID: 33509300
    [Abstract] [Full Text] [Related]

  • 27. Long-term exposure to estrogen enhances chemotherapeutic efficacy potentially through epigenetic mechanism in human breast cancer cells.
    Chang YW, Singh KP.
    PLoS One; 2017 Jan 28; 12(3):e0174227. PubMed ID: 28323900
    [Abstract] [Full Text] [Related]

  • 28. Growth factors and chemotherapeutic modulation of breast cancer cells.
    Ciftci K, Su J, Trovitch PB.
    J Pharm Pharmacol; 2003 Aug 28; 55(8):1135-41. PubMed ID: 12956904
    [Abstract] [Full Text] [Related]

  • 29. Inhibition of fucoidan on breast cancer cells and potential enhancement of their sensitivity to chemotherapy by regulating autophagy.
    Zhang N, Xue M, Wang Q, Liang H, Yang J, Pei Z, Qin K.
    Phytother Res; 2021 Dec 28; 35(12):6904-6917. PubMed ID: 34687482
    [Abstract] [Full Text] [Related]

  • 30. In vitro effects of Sutherlandia frutescens water extracts on cell numbers, morphology, cell cycle progression and cell death in a tumorigenic and a non-tumorigenic epithelial breast cell line.
    Stander A, Marais S, Stivaktas V, Vorster C, Albrecht C, Lottering ML, Joubert AM.
    J Ethnopharmacol; 2009 Jul 06; 124(1):45-60. PubMed ID: 19527821
    [Abstract] [Full Text] [Related]

  • 31. Anticancer Activity of Fucoidan via Apoptosis and Cell Cycle Arrest on Cholangiocarcinoma Cell.
    Chantree P, Na-Bangchang K, Martviset P.
    Asian Pac J Cancer Prev; 2021 Jan 01; 22(1):209-217. PubMed ID: 33507701
    [Abstract] [Full Text] [Related]

  • 32. (-)-Hinokinin Induces G2/M Arrest and Contributes to the Antiproliferative Effects of Doxorubicin in Breast Cancer Cells.
    Cunha NL, Teixeira GM, Martins TD, Souza AR, Oliveira PF, Símaro GV, Rezende KC, Gonçalves Ndos S, Souza DG, Tavares DC, Silva ML, Dos Santos RA.
    Planta Med; 2016 Apr 01; 82(6):530-8. PubMed ID: 27002393
    [Abstract] [Full Text] [Related]

  • 33. Cerivastatin demonstrates enhanced antitumor activity against human breast cancer cell lines when used in combination with doxorubicin or cisplatin.
    Kozar K, Kaminski R, Legat M, Kopec M, Nowis D, Skierski JS, Koronkiewicz M, Jakóbisiak M, Golab J.
    Int J Oncol; 2004 May 01; 24(5):1149-57. PubMed ID: 15067336
    [Abstract] [Full Text] [Related]

  • 34. Xiaoaiping combined with cisplatin can inhibit proliferation and invasion and induce cell cycle arrest and apoptosis in human ovarian cancer cell lines.
    Zheng AW, Chen YQ, Fang J, Zhang YL, Jia DD.
    Biomed Pharmacother; 2017 May 01; 89():1172-1177. PubMed ID: 28320083
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Reactivity of monoclonal antibody FC-2.15 against drug resistant breast cancer cells. Additive cytotoxicity of adriamycin and taxol with FC-2.15.
    Ballaré C, Portela P, Schiaffi J, Yomha R, Mordoh J.
    Breast Cancer Res Treat; 1998 Jan 01; 47(2):163-70. PubMed ID: 9497104
    [Abstract] [Full Text] [Related]

  • 37. Effect of Chemotherapeutics and Tocopherols on MCF-7 Breast Adenocarcinoma and KGN Ovarian Carcinoma Cell Lines In Vitro.
    Figueroa D, Asaduzzaman M, Young F.
    Biomed Res Int; 2019 Jan 01; 2019():6146972. PubMed ID: 30766885
    [Abstract] [Full Text] [Related]

  • 38. Effect of recombinant human erythropoietin and doxorubicin in combination on the proliferation of MCF-7 and MDA-MB231 breast cancer cells.
    Radwan EM, Abdullah R, Al-Qubaisi MS, El Zowalaty ME, Naadja SE, Alitheen NB, Omar AR.
    Mol Med Rep; 2016 May 01; 13(5):3945-52. PubMed ID: 26987078
    [Abstract] [Full Text] [Related]

  • 39. Phosphatidylinositol 3-kinases inhibitor LY294002 potentiates the cytotoxic effects of doxorubicin, vincristine, and etoposide in a panel of cancer cell lines.
    Badinloo M, Esmaeili-Mahani S.
    Fundam Clin Pharmacol; 2014 Aug 01; 28(4):414-22. PubMed ID: 23837575
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.